2 terminated. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
| Phase 3 | 1 | Terminated 1 |
Follow Bone Cancer: new trials by email Literature Review of Bone Cancer trials Research Report on Bone Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma Irinotecan, Vincristine, Temozolomide - Bone Cancer, Ewing's Sarcoma | Phase 2 | Terminated | Stanford University | 3 | 2011-05-01 | 2017-11-24 |
| Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia Enbrel - Lung Cancer, Prostate Cancer | Phase 2 / Phase 3 | Terminated | The University of Texas Health Science Center at San Antonio | 54 | 2001-05-01 | 2012-06-26 |
Bone Neoplasms (2) · Lung Neoplasms (1) · Neoplasm Metastasis (1) · Prostatic Neoplasms (1) · Sarcoma, Ewing (1)
Bone Diseases (2) · Musculoskeletal Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Genital Diseases (1) · Genital Diseases, Male (1) · Genital Neoplasms, Male (1) · Lung Diseases (1) · Male Urogenital Diseases (1) · Neoplasms by Histologic Type (1) · Neoplasms, Bone Tissue (1) · Neoplasms, Connective Tissue (1) · Neoplasms, Connective and Soft Tissue (1) · Neoplastic Processes (1) · Osteosarcoma (1)
Cyclophosphamide (1) · Doxorubicin (1) · Etanercept (1) · Irinotecan (1) · Temozolomide (1) · Vincristine (1) · pegfilgrastim (1)
Stanford University (1) · The University of Texas Health Science Center at San Antonio (1)
United States (2)
Charles R Thomas, Jr, MD (1) · Kristen N. Ganjoo (1)